E
Elliott M. Antman
Researcher at Brigham and Women's Hospital
Publications - 738
Citations - 187175
Elliott M. Antman is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Myocardial infarction & TIMI. The author has an hindex of 161, co-authored 716 publications receiving 179462 citations. Previous affiliations of Elliott M. Antman include Duke University & Katholieke Universiteit Leuven.
Papers
More filters
Journal ArticleDOI
Comparison of a 60- versus 90-minute determination of ST-segment resolution after thrombolytic therapy for acute myocardial infarction
James A. de Lemos,Elliott M. Antman,Robert P. Giugliano,David A. Morrow,Carolyn H. McCabe,Sally S. Cutler,Andrew Charlesworth,Rolf Schröder,Eugene Braunwald +8 more
TL;DR: Determination of ST-segment resolution 60 minutes after the administration of thrombolytic therapy allows accurate risk stratification for mortality and congestive heart failure and patients with complete ST resolution at 90 minutes tended to be at lower risk for 30-day mortality.
Journal ArticleDOI
Pharmacoinvasive Therapy The Future of Treatment for ST-Elevation Myocardial Infarction
TL;DR: Care of patients with STEMI will be improved in the future if they are viewed as a single integrated effort at reperfusion, according to the authors.
Journal ArticleDOI
Time to Coronary Angiography and Outcomes Among Patients With High-Risk Non–ST-Segment–Elevation Acute Coronary Syndromes Results From the SYNERGY Trial
Pierluigi Tricoci,Yuliya Lokhnygina,Lisa G. Berdan,Steven R. Steinhubl,Dietrich C. Gulba,Harvey D. White,Neal S. Kleiman,Philip E. Aylward,Anatoly Langer,Robert M. Califf,James J. Ferguson,Elliott M. Antman,L. Kristin Newby,Robert A. Harrington,Shaun G. Goodman,Kenneth W. Mahaffey +15 more
TL;DR: A decrease in the time to coronary angiography was associated with fewer ischemic outcomes and no increase in bleeding and Randomized clinical trials are needed to provide definitive evidence on optimal timing of coronaryAngiography.
Journal ArticleDOI
Effects of prior aspirin and anti-ischemic therapy on outcome of patients with unstable angina. TIMI 7 Investigators. Thrombin Inhibition in Myocardial Ischemia.
Steven Borzak,Christopher P. Cannon,Phillip Kraft,Lori Douthat,Richard C. Becker,Sebastian T. Palmeri,Timothy D. Henry,Judith S. Hochman,Joanna Fuchs,Elliott M. Antman,Carolyn H. McCabe,Eugene Braunwald +11 more
TL;DR: Aspirin but not anti-ischemic therapy before hospitalization of patients with unstable angina was associated with a decreased incidence of non–Q-wave AMI on admission, which was best predicted by age and electrocardiographic changes with pain.
Journal ArticleDOI
Combined assessment of thrombolysis in myocardial infarction flow grade, myocardial perfusion grade, and ST-segment resolution to evaluate epicardial and myocardial reperfusion.
Robert P. Giugliano,Robert P. Giugliano,Marc S. Sabatine,Marc S. Sabatine,C. Michael Gibson,C. Michael Gibson,Matthew T. Roe,Matthew T. Roe,Robert A. Harrington,Robert A. Harrington,Sabina A. Murphy,Sabina A. Murphy,David A. Morrow,David A. Morrow,Elliott M. Antman,Elliott M. Antman,Eugene Braunwald,Eugene Braunwald +17 more
TL;DR: A new end point is proposed to evaluate the success of reperfusion therapy in patients who undergo early angiography, and attainment of the trifecta at 60 minutes remained a strong predictor of better clinical outcomes, particularly in those patients who underwent early PCI.